Publications by authors named "L Descamps"

T-shaped partial least squares regression (T-PLSR) is a valuable machine learning technique for the formulation and manufacturing process development of new drug products. An accurate T-PLSR model requires experimental data with multiple formulations and process conditions. However, it is usually challenging to collect comprehensive experimental data using large-scale manufacturing equipment because of the cost, time, and large consumption of raw materials.

View Article and Find Full Text PDF

Circulating tumor cells (CTCs) isolated directly from whole blood opens new perspectives for cancer monitoring and the development of personalized treatments. However, due to their rarity among the multitude of blood cells, it remains a challenge to recover them alive with high level of purity, i.e.

View Article and Find Full Text PDF

The current study aimed at optimizing a previously developed non-clinical formulation for use in zolpidem deprescribing. The formulation under investigation consists of extruded zolpidem hemitartrate (30% w/w) and Eudragit EPO (70% w/w) mixtures which display unsatisfactory dissolution behavior. Both milled extrudates and physical mixtures were compressed to produce tablets with identical target weight and solid fraction.

View Article and Find Full Text PDF

Cytotoxic T-cells (CTLs) exhibit strong effector functions to leverage antigen-specific anti-tumoral and anti-viral immunity. When naïve CTLs are activated by antigen-presenting cells (APCs) they display various levels of functional heterogeneity. To investigate this, we developed a single-cell droplet microfluidics platform that allows for deciphering single CTL activation profiles by multi-parameter analysis.

View Article and Find Full Text PDF
Article Synopsis
  • The isolation of circulating tumor cells (CTCs) from blood offers potential benefits for cancer diagnosis and treatment, but challenges like their rarity and diversity have limited clinical use.
  • The researchers developed the MagPure chip, a microfluidic device, which effectively removes white blood cells and isolates highly pure CTC samples while achieving a high recovery rate.
  • This device works well with standard biological studies and allows for a rapid blood processing workflow, making it possible to analyze CTC characteristics that can help assess cancer aggressiveness and prognosis.
View Article and Find Full Text PDF